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Appendix 1: Assessment of methodological quality of studies 
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Jinbayash et al. Y  Y  Y  Y  N  N  4 
Burger et al. Y  Y  Y  Y N  N  4 
Greendale et al. N  Y  Y  Y Y  N  4 
Huang et al. Y  Y  Y  Y Y  Y  6 
O’Neill et al. Y  Y  Y  Y Y  N  5 
Edmond et al. Y  Y  Y  Y Y  N  5 
Chan et al.  Y  Y  Y  Y N  N  4 
Ling et al. Y  Y  Y  Y N  N  4 
Silman et al. Y  Y  Y  Y N  N  4 
Ismail et al. Y  Y  Y  Y N  N  4 
Lau et al. Y  Y  Y  Y N  N 4 
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25(6): p. 1775-84. 
Sornay-Rendu, E., et al., Rate of forearm bone loss is associated with an increased risk of fracture independently of bone 
mass in postmenopausal women: the OFELY study. J Bone Miner Res, 2005. 20(11): p. 1929-35.  
Physical performance was measured objectively (12 studies) 
Cheung, C.L., et al., Low handgrip strength is a predictor of osteoporotic fractures: cross-sectional and prospective 
evidence from the Hong Kong Osteoporosis Study. Age (Dordr), 2012. 34(5): p. 1239-48. (all types) 
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2007. 18(1): p. 35-43. 
Pasco, J.A., et al., Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality 
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Figure 1   
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